Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

510.08
+6.831.36%
Post-market: 510.00-0.0800-0.02%19:48 EDT
Volume:1.48M
Turnover:755.94M
Market Cap:129.42B
PE:29.69
High:514.90
Open:502.11
Low:502.06
Close:503.25
52wk High:560.25
52wk Low:402.58
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.50
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.39
PE(LYR):33.30

Loading ...

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
4 hours ago

Vertex Pharmaceuticals to present data on Alyftrek at NACFC

TIPRANKS
·
7 hours ago

Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function

Reuters
·
8 hours ago

Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors

TIPRANKS
·
8 hours ago

Vertex to Raise Up to C$7 Million in Subordinated Loan with Attached Warrants

TIPRANKS
·
Yesterday

Press Release: Vertex Resource GROUP LTD. Announces Subordinated TERM LOAN of up to C$7,000,000

Dow Jones
·
Yesterday

Vertex Pharmaceuticals price target raised to $576 from $570 at RBC Capital

TIPRANKS
·
Oct 08

RBC Lifts Price Target on Vertex Pharmaceuticals to $576 From $570, Keeps Outperform Rating

MT Newswires Live
·
Oct 08

Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast

Reuters
·
Oct 08

Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project

TIPRANKS
·
Oct 06

Vertex Minerals lodges 2026 corporate governance statement with ASX

TIPRANKS
·
Oct 02

Vortex Energy Expands Saskatchewan Portfolio with Meadows Project Acquisition

TIPRANKS
·
Oct 02

Vertex adds AI-focused independent director to board

TIPRANKS
·
Oct 02

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Oct 02

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Oct 02

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.21% on Oct 1: What Investors Need To Know

TradingKey
·
Oct 02

Movement Alert|Vertex Pharmaceuticals Declines 3.03% in Regular Trading, Trading at $506.63

Market Focus
·
Oct 02

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-01

Reuters
·
Oct 02

Vertex appoints Saha to Board of Directors

TIPRANKS
·
Oct 01

Press Release: Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors

Dow Jones
·
Oct 01